Currently licensed weight management medications in the UK include: Orlistat (lipase inhibitor that reduces fat absorption) Wegovy (semaglutide injection) for chronic weight management (typically BMI 35 kg/m, or 30 kg/m with weight-related comorbidities, via specialist weight management services) [13] Saxenda (liraglutide injection) , another GLP-1 receptor agonist (typically BMI 35 kg/m, or 30 kg/m with weight-related comorbidities) Mysimba (naltrexone/bupropion) is licensed but not routinely commissioned by the NHS [15] [16] NICE recommends lower BMI thresholds (typically 2.5 kg/m lower) for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds
Effective & professional doctor-led Mounjaro at our central London clinic Verified Before & After Verified Before & After MHRA Guidance: Use non-hormonal contraception (eg, patch, ring, IUD) during therapy
Metabolismo Quertaro El Triple Agonista
Metabolic improvements (blood sugar, weight loss, body composition) typically become evident at 6-12 weeks
Because they are not approved by the FDA for human use, dosing, purity, and safety cannot be guaranteed
Griffeth RJ, Bianda V, Nef S
